During the past decade, Cancer Center of Acadiana conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 10 clinical trials were completed, i.e. on average, 333.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Center of Acadiana" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "AVEO Pharmaceuticals, Inc." with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Center of Acadiana" #1 collaborator was "AbbVie" with 2 trials as a collaborator, "Biodesix, Inc." with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Center of Acadiana" are "Multiple Myeloma" (2 trials), "Borderline Ovarian Mucinous Tumor" (1 trials), "Breast Cancer" (1 trials), "Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Cancer Center of Acadiana" in a lesser frequency.

Most popular intervention types in "Cancer Center of Acadiana" are "Drug" (11 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (3 trials), "Placebo" (3 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Center of Acadiana" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Center of Acadiana". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Cancer Center of Acadiana, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Center of Acadiana, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".